Li, Y., Dai, C., Yang, H., Zeng, H., Ruan, Y., Dai, M., . . . Ji, F. (2024). Cross‐sectional and Mendelian randomization study of fibroblast growth factor 19 reveals causal associations with metabolic diseases. Journal of gastroenterology and hepatology, 39(12), 2872-2879. https://doi.org/10.1111/jgh.16687
Citácia podle Chicago (17th ed.)Li, Yan, et al. "Cross‐sectional and Mendelian Randomization Study of Fibroblast Growth Factor 19 Reveals Causal Associations with Metabolic Diseases." Journal of Gastroenterology and Hepatology 39, no. 12 (2024): 2872-2879. https://doi.org/10.1111/jgh.16687.
Citácia podľa MLA (8th ed.)Li, Yan, et al. "Cross‐sectional and Mendelian Randomization Study of Fibroblast Growth Factor 19 Reveals Causal Associations with Metabolic Diseases." Journal of Gastroenterology and Hepatology, vol. 39, no. 12, 2024, pp. 2872-2879, https://doi.org/10.1111/jgh.16687.